Benznidazole is approved by the FDA for children 2-12 years of age but is commercially available for patients with Chagas disease without limitation of age. Nifurtimox is approved by the FDA for children from birth to 18 years of age
Optimal duration of therapy has not been established in patients with HIV
Action required
Login now to access all of your entitled content
or